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19.1 Introduction
With the increasing interest in individualized medicine there is a greater need for robust
statistical methods for prediction of optimal treatment based on the patient’s characteristics.
When evaluating two treatments, one treatment may not be uniformly superior to the other
treatment for all patients. A patient characteristic may interact with one of the treatments
and change the effect of the treatment on the response. Clinical trials are also collecting
more information on the patient. This additional information on the patients combined with
the state-of-the-art in model selection allows researchers to build better optimal treatment
algorithms.
In this chapter we introduce a methodology for predicting optimal treatment. The
methodology is demonstrated first on a simulation and then on a phase III clinical trial
in neuro-oncology.
19.2 Predicting Optimal Treatment Based on Baseline Factors
Start with a randomized controlled trial where patients are assigned to one of two treat-
ment arms, A ∈ {0, 1}, with Pr(A = 1) = ΠA. The main outcome for the trial is defined
at a given time point t as Y = I(T > t) where T is the survival time. For example, the
main outcome may be the six-month progression-free rate and T is the progression time.
Also collected at the beginning of the trial is a set of baseline covariates W . The baseline
covariates may be any combination of continuous and categorical variables. The baseline
covariates can be split into prognostic and predictive factors. Prognostic factors are patient
characteristics which are associated with the outcome independent of the treatment given,
while predictive factors are patient characteristics which interact with the treatment in their
association with the outcome. To determine the optimal treatment, a model for how the
predictive factors and treatment are related to the outcome needs to be estimated.
The observed data is Oi = (Wi, Ai, Yi = I(Ti > t)) ∼ P for i = 1, . . . , n. For now assume
Y is observed for all patients in the trial but this assumption is relaxed in the next section.
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The optimal treatment given a set of baseline variables is found using theW -specific variable
importance parameter:
Ψ(W ) = E(Y |A = 1,W )− E(Y |A = 0,W ) (19.1)
Ψ(W ) is the additive risk difference of treatment A for a specific level of the prognostic vari-
ables W . The conditional distribution of Y given W is defined as {Y |W} ∼ Bernoulli(piY ).
The subscript W is assumed on piY and left off for clarity of the notation. Adding the treat-
ment variable A into the conditioning statement we define {Y |A = 1,W} ∼ Bernoulli(pi+1)
and {Y |A = 0,W} ∼ Bernoulli(pi−1). Again the subscript W is dropped for clarity but
assumed throughout the paper. The parameter of interest can be expressed as Ψ(W ) =
pi+1 − pi−1. For a given value of W , Ψ(W ) will fall into one of three intervals with each
interval leading to a different treatment decision. The three intervals for Ψ(W ) are:
1. Ψ(W ) > 0 : indicating a beneficial effect of the intervention A = 1.
2. Ψ(W ) = 0 : indicating no effect of the intervention A.
3. Ψ(W ) < 0 : indicating a harmful effect of the intervention A = 1.
Knowledge of Ψ(W ) directly relates to knowledge of the optimal treatment.
As noted in [1], the parameter of interest can be expressed as:










When ΠA = 0.5, the conditional expectation in equation (19.2) can be modeled with the




+1 if Y = 1 & A = 1
0 if Y = 0
−1 if Y = 1 & A = 0
The observed values of Z follow a multinomial distribution. The parameter Ψ(W ) will be
high dimensional in most settings and the components of Ψ(W ) are effect modifications
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between W and the treatment A on the response Y . The parameter can be estimated with
a model Ψ(W ) = m(W |β). The functional form of m(W |β) can be specified a priori, but
since the components of the model represent effect modifications, knowledge of a reasonable
model may not be available and we recommend a flexible approach called the super learner
(described in the next section) for estimating Ψ(W ). In many cases a simple linear model
may work well for m(W |β), but as the true functional form of Ψ(W ) becomes more complex,
the super learner gives the researcher flexibility in modeling the optimal treatment function.
With the squared error loss function for a specific model m(W |β), the parameter estimates
are:





The treatment decision for a new individual with covariates W = w is to treat with A = 1
if m(w|βn) > 0, otherwise treat with A = 0.
A normal super learner model for m(W |β) would allow for a flexible relationship between
W and Z but these models do not respect the fact that Ψ(W ) is bounded between−1 and +1.
The regression of Z onW does not use the information that the parameter Ψ(W ) = pi+1−pi−1
is bounded between −1 and +1. The estimates in equation (19.3) have a nice interpretation
since the model predicts the additive difference in survival probabilities. In proposing an
alternative method, we wanted to retain the interpretation of an additive effect measure but
incorporate the constrains on the distributions. Starting with the parameter of interest in
equation (19.1) we add a scaling value based on the conditional distribution of Y given W
as in:
Ψ′(W ) =
EP (Y |A = 1,W )− EP (Y |A = 0,W )




Since piY = Pr(Y = 1|W ) = Pr(Z 6= 0|W ), the new parameter Ψ′(W ) = E(Z|Z 6= 0,W ).
When we restrict the data to the cases with Z 6= 0 (i.e. Y = 1) the outcome becomes
a binary variable and binary regression methods can be implemented. For example, the
logistic regression model:
logit (Pr(Z = 1|Z 6= 0,W )) = m′(Wi|β) (19.5)
The treatment decision is based on m′(Wi|βn) > 0 where βn is the maximum likelihood
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estimate for the logistic regression model. With the binary regression setting, we are now
incorporating the distribution information in creating the prediction model, but losing in-
formation by working on a subset of the data. These trade-offs depend on the probability
piY and we will evaluate both methods on the trial example below. In the next section we
propose a data-adaptive method for estimating Ψ(W ).
19.3 Super Learner
Many methods exist for prediction, but for any given data set it is not known which
method will give the best prediction. A good prediction algorithm should be flexible to
the true data generating distribution. One such algorithm is the super learner [2]. The
super learner is applied to predict the optimal treatment based on the observed data. The
super learner algorithm starts with the researcher selecting a set of candidate prediction
algorithms (candidate learners). This list of candidate learners should be selected to cover
a wide range of basis functions. The candidate learners are selected prior to analyzing the
data; selection of the candidates based on performance on the observed data may introduce
bias in the final prediction model. A flow diagram for the super learner algorithm is provided
in figure 19.1. With the candidate learners selected and the data collected, the initial step
is to fit all of the candidate learners on the entire data set and save the predicted values for
Ψn(W ) = mj(W |βn), where j indexes the candidate learners. The data is then split into
V equal sized and mutually exclusive sets as is typically done for V-fold cross-validation.
Patients in the vth fold are referred to as the vth validation set, and all patients not in the
vth fold are referred to as the vth training set. For the vth fold, each candidate learner is
fit on the patients in the vth training set and the predicted values for Ψ(W ) = mj(W |βn)
for the patients in the vth validation set are saved. This process of training the candidate
learners on the out of fold samples and saving the predicted values in the fold is repeated
for all V folds. The predictions from all V folds are stacked together in a new data matrix
Xv. With the prediction data, regress the observed outcome Z on the columns of Xv, which
represent the predicted outcomes for each candidate learner. This regression step selects
weights for each candidate learner to minimize the cross-validated risk. With the estimates,
βn, from the model E(Z|Xv) = m(X|β) the super learner only saves the weights (βn) and
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the functional form of the model. The super learner prediction is then based on combining
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. E(Z|X) = m(X;β)
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Figure 19.1: Flow diagram for super learner
19.4 Extensions for Censored Data
In a prospective trial the data may be subject to right censoring. In both methods above,
right censoring leads to the outcome Z being missing. The data structure is extended to
include an indicator for observing the outcome. Let C be the censoring time (for individ-
uals with an observed outcome we set C = ∞). Define ∆ = I(C > t). ∆ = 1 when the
outcome is observed and ∆ = 0 when the outcome is missing. The observed data is the set
(W,A,∆, Y∆). For the first method, we propose using the doubly robust censoring unbiased
transformation [3]. The doubly robust censoring unbiased transformation generates a new
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variable Z∗ which is a function of the observed data but has the additional property:
E (Z∗|W,∆ = 1) = E (Z|W )
The transformation allows estimation of the parameter Ψ(W ) by applying the super learner
on the uncensored observations with the transformed variable Z∗ as the outcome. The doubly






Q(W ) +Q(W ), (19.6)
where pi(W ) = Pr(∆ = 1|W ) and Q(W ) = E(Z|W,∆ = 1). Both pi(W ) and Q(W ) need
to be estimated from the data. If either pi(W ) or Q(W ) is consistently estimated, then
the prediction function E(Z∗|W,∆ = 1) = m(W |βn) is an unbiased estimate for the true
parameter Ψ(W ). The censoring mechanism pi(W ) can be estimated with a logistic regression
model or a binary super learner on the entire data set. Similarly, Q(W ) may be fit with a
linear regression model or a super learner, but on the subset of the data with observed values
for Z.
For the second method which relies on modeling E(Z|Z 6= 0,W ), the main feature was
the ability to use the knowledge of the distributions to develop a better model. To retain
the binary outcome, the doubly robust censoring unbiased transformation will not work. An
alternative method for the right censoring which will retain the binary outcome would be
inverse probability of censoring weighting. Inverse probability of censoring weights uses the
same pi(W ) as above, but does not incorporate the other nuisance parameter Q(W ). When
applying the binary super learner for E(Z|Z 6= 0,W,∆ = 1) the weights 1/pi(W ) will be
applied for both the candidate learners and the V-fold cross-validation steps. The super
learner will minimize the weighted loss function.
19.5 Simulation Example
We first demonstrate the proposed method on a simulation example where the true value
of Ψ(W ) is known. The baseline variables were all simulated as normally distributed, Wj ∼
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N(0, 1), j = 1, . . . , 10. The treatment was randomly assigned with ΠA = 0.5. The true
model for the outcome was:
Pr(Y = 1|A,W ) = g−1(0.405A− 0.105W1 + 0.182W2 + 0.039AW2 (19.7)
+0.006AW2W3 − 0.357AW4 − 0.020AW5W6 − 0.051AW6)
Where g−1(·) is the inverse logit function and Wj refers to the jth variable in W . The true
model was selected to include interactions between the treatment and some of the baseline
variables. With knowledge of the true model for the outcome Y , the true value of Ψ(W ) is
calculated for every individual.
The first method involves the regression of Z on W . We applied the super learner for
m(W |β). 10-fold cross validation was used for estimating the candidate learner weights in
the super learner. The super learner for the first method included five candidate learners.
The first candidate was ridge regression [4]. Ridge regression used an internal cross valida-
tion to select the penalty parameter. Internal cross validation means the candidate learner
performed a V-fold cross validation procedure within the folds for the super learner. Struc-
turally, when the candidate learner also performs cross validation within the super learner
cross validation we have nested cross validation; therefore, we refer to the candidate learner
cross validation as internal cross validation. The second candidate was random forests [5].
For the random forest candidate learner, 1000 regression trees were grown. The third can-
didate was least angle regression [6]. An internal 10-fold cross validation procedure was
used to determine the optimal ratio of the L1 norm of the coefficient vector compared to
the L1 norm of the full least squares coefficient vector. The fourth candidate was adaptive
regression splines for a continuous outcome [7]. The final candidate was linear regression.
Table 19.1 contains reference for the R packages implemented for the candidate learners in
the super learner.
The prediction model from the super learner is:
Ψn(W ) = −0.01 + 7.24(Xridgen ) + 1.16(Xrfn )− 0.20(X larsn )− 7.07(X lmn )− 0.03(Xmarsn )
Where Xjn is the predicted value for Z based on the jth candidate learner. j = ridge is the
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Method R Package Authors
Adaptive Regression Splines polspline Kooperberg
Least Angle Regression lars Efron and Hastie
Penalized Logistic stepPlr Park and Hastie
Random Forests randomForest Liaw and Wiener
Ridge Regression MASS Venables and Ripley
Table 19.1: R Packages for Candidate Learners. R is available at http://www.r-project.
org
ridge regression model. j = rf is the random forests model. j = lars is the least angle
regression model. j = lm is the main effects linear regression model. j = mars is the
adaptive regression splines model. The largest weights are for ridge regression and the linear
regression model. For example, the estimates for the linear regression model is:
X lmn = 0.06 + 0.02W1 + 0.01W2 − 0.03W3 − 0.07W4 + 0.01W5 + 0.05W6
− 0.02W7 − 0.00W8 − 0.01W9 − 0.06W10.
The linear regression model has the largest coefficient on W4, which is the variable with the
strongest effect modification with the treatment in the true model (equation (19.7)). The
second largest coefficient is on W10 which is a variable unrelated to the outcome. The super
learner helps smooth over these errors by having multiple candidate learners. For example,
W10 has a small coefficient (−0.01) in the ridge regression model. When all the candidates
are combined into the final super learner prediction model the spurious effect estimates will
often disappear resulting in a better predictor. The third largest coefficient from the linear
regression model is on W6 which is also a strong effect modifier in the true model. To
evaluate how the super learner is performing in comparison to the other candidate learners,
each candidate learner was also fit as a separate estimate. We looked at two risk values,
first the E(Ψn(W ) − Z)2 which was minimized by each algorithm. For the simulation, the
risk Eˆ(Z −Ψ(W ))2 = 0.540 gives a lower bound for the risk E(Ψn(W )−Z)2. Since the true
Ψ(W ) is known in the simulation, the risk E(Ψn(W ) − Ψ(W ))2 was also evaluated. Table
19.2 contains the risk values for the simulation. The super learner achieved the smallest
E(Ψn(W )− Z)2 and is comparable to MARS and LARS on the risk for the true parameter
value Ψ(W ).
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E(Ψn(W )−Ψ(W ))2 E(Ψn(W )− Z)2




Linear Model 0.028 0.559
Random Forests 0.038 0.565
Table 19.2: Risk for all candidate learners and the super learner
The super learner for the second method included three candidate learners. The first
candidate was adaptive regression splines for polychotomous outcomes [8]. The second can-
didate was the step-wise penalized logistic regression algorithm [9]. The final candidate was
main terms logistic regression. The super learner for the second method is:
Ψ′n(W ) = −1.20 + 1.43(Xpolyn )− 0.50(Xplrn ) + 1.61(Xglmn )
Where Xjn is the predicted value for Z based on the jth candidate learner. j = poly is the
polyclass adaptive spline model. j = plr is the penalized logistic regression model. j = glm
is the main effects logistic regression model.
19.6 Example of Prediction Model on Clinical Trial
A phase III clinical trial was conducted to evaluate a novel treatment for brain metastasis.
The study recruited 554 patients with newly diagnosed brain metastasis and the patients
were randomized to receive either standard care (A = 0) or the novel treatment (A = 1). The
researchers were interested in determining an optimal treatment to maximize the probability
of surviving 6 months from treatment initiation without progression. Of the 554 patients, 246
are censored prior to 6 months. For the 308 patients with an observed 6 month progression
time, 130 progressed or died (42.2%). In addition to the treatment and event time data, the
researchers collected baseline prognostic and predictive factors on every patient. We apply
the super learner to estimate a model for selecting the optimal treatment given a patient’s
baseline factors. A breakdown of the sample size and treatment allocations available for each
method is given in table 19.3.
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A
total 0 1
Enrolled 554 275 279
Method 1 308 158 150
Method 2 130 67 63
Table 19.3: Number of subjects in each treatment arm at enrollment and available for each
method.
19.6.1 Super learner for optimal treatment decisions
Both methods proposed above were applied to the data. The first method looks for a
model of Z on W treating Z as a continuous variable. The second method looks for a model
of Z on W conditional on Z 6= 0 treating the outcome as binary.
The same super learners from the simulation example above were used here in the trial
example. The predicted model for the first method is:
Ψn(W ) = −0.01 + 0.02(Xridgen ) + 1.21(Xrfn )− 0.84(X larsn )− 0.28(X lmn ) + 0.50(Xmarsn )
Where Xjn is the predicted value for Z based on the jth candidate learner. j = ridge is
the ridge regression model. j = rf is the random forests model. j = lars is the least
angle regression model. j = lm is the main effects linear regression model. j = mars is
the adaptive regression splines model. The coefficient estimates for each candidate learner
from the super learner can be interpreted as a weight for each candidate learner in the final
prediction model. Random forests has the largest absolute weight. When interpreting the
weights, be cautious of the often near collinearity of the columns of X. To evaluate the
super learner in comparison to the candidate learners, a 10-fold cross validation of the super
learner and each of the candidate learners themselves was used to estimate E(Ψn(W )−Z)2.
Table 19.4 contains the risk estimates. For the trial example, both the lars algorithm and the
mars algorithm outperform the super learner. As observed in the simulation, minimizing the
risk E(Ψn(W )−Z)2 should directly relate to minimizing the risk E(Ψn(W )−Ψ(W ))2. These
cross-validation estimates may be used to select an optimal final model for the treatment
decisions.
The second method evaluates E(Z|Z 6= 0,W ) = m′(W |β). The estimated super learner








Table 19.4: 10-fold honest cross validation estimates of E(Ψn(W )−Z)2 for the super learner
and each of the candidate learners on their own.
model for the second method is:
Ψ′n(W ) = −0.53− 0.40(Xpolyn ) + 0.55(Xplrn ) + 0.81(Xglmn )
Where Xjn is the predicted value for Z based on the jth candidate learner. j = poly is
the polyclass adaptive spline model. j = plr is the penalized logistic regression model.
j = glm is the main effects logistic regression model. To compare the two methods, we


















Figure 19.2: Histograms from 1000 bootstrap samples for Ψ′(W = w¯) and Ψ(W = w¯). The
number in the title bar refers to the method used.
created a confidence interval at the mean vector for W . Let w¯ be the vector of observed
means for the baseline variables using all observations in the trial. Confidence intervals were
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created based on 1000 bootstrap samples of the entire super learner. The 95% confidence
interval for m(w¯|β) based on the first method is (−0.20, 0.52). The 95% for m(w¯|β) based
on the second method is (−2.23, 1.23). Although the second method is able to use the
distributional information, the penalty for the smaller sample size is great (308 patients for
the first method down to 130 patients for the second method). As can be seen in figure 19.2,
the second method has a wide confidence interval compared to the first method.
19.7 Variable Importance Measure
An additional feature of having a good prediction model is better variable importance
measures. The variables in E(Z|W ) are effect modifications and when applying the targeted
maximum likelihood estimation (tMLE) variable importance measure [10] the results will
be causal effect modification importance measures. The targeted maximum likelihood effect
modification variable importance allows the researcher to focus on each variable in W indi-
vidually while adjust for the other variables inW . An initial variable importance estimate is
based on an univariate regression, Z∗ = β0j + β1jWj, j = 1, . . . , p where p is the number of
baseline covariates in W . The top 5 baseline variables based on the ranks of the univariate
p-values is presented in table 19.5. The top unadjusted effect modification variable is an
indicator of whether the patients lives in the US or Europe, followed by an indicator for
the patients being in RPA class 2, an indicator for the primary tumor being controlled, an
indicator for extracranial metastasis, and finally an indicator for the patient’s age greater
than 65 years. The top 5 baseline variables from the LARS procedure are similar to those
from the univariate regression with the exception of Squamous cell indicator replacing the
RPA class 2 indicator. For the tMLE variable importance, the effect of Wj on Z is adjusted
by all other covariates in W . Let W(−j) be all covariates in W excluding the jth variable.
The targeted maximum likelihood variable importance measure as outlined in [11] was then
applied using the predictions from the super learner as the initial estimate of E(Z|W ). The
targeted effect modification parameter is then:
ψj = E
(
E(Z|Wj = 1,W(−j))− E(Z|Wj = 0,W(−j))
)
, j = 1, . . . , p (19.8)
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Method Baseline Variable Effect p-value
Univariate Regression US vs Europe -0.222 0.007
RPA class 2 -0.229 0.017
Primary tumor control 0.165 0.052
Extracranial mets -0.133 0.069
Age > 65 years -0.157 0.075
LARS US vs Europe -0.124 0.350
Primary tumor control 0.080 0.405
Age > 65 years -0.050 0.412
Extracranial mets -0.028 0.413
Squamous cell 0.034 0.419
tMLE Mets Dx > 6 Mo 0.864 <0.001
Squamous cell 1.012 <0.001
Adeno carcinoma 0.129 0.007
Extracranial mets -0.102 0.022
Caucasian 0.172 0.035
Table 19.5: Top 5 effect modifiers based on univariate regression, lars, and super learner
with targeted maximum likelihood. The standard error was based on a bootstrap with 1,000
samples.
The top 5 baseline variables are presented in table 19.5. The effect estimates from the tMLE
procedure can be considered causal effect modifiers. Only extracranial mets appears in both
the adjusted and unadjusted top 5 list, although squamous cell indicator does appear in both
the LARS procedure and the tMLE procedure. The top variable (Mets Dx > 6 Mo) is an
indicator for the metastasis diagnosis occurring greater than 6 months after prvious cancer.
The tMLE list contains two indicators for histology of the tumor cells (Squamous and Adeno
carcinoma) suggesting that some tumor types my respond better to the treatment compared
to others. Comparing the variable importance lists, the indicator for the patient being in
the United States compared to Europe is on top of the list for the univariate regression
and the lars model, but absent from the tMLE list. There is no biological evidence for
geographical location to interact with the treatment in this trial. The variable importance
based on targeted maximum likelihood is able to appropriately adjust for the confounding
on the other variables in W and remove the US versus Europe indicator from the list of top
variables. The variable importance list from the tMLE has a better interpretation and is
informative as to which patient characteristics have a causal interaction with the treatment.
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19.8 Discussion
Two methods were proposed for predicting the optimal treatment based on baseline fac-
tors. The first method involves modeling Z on W disregarding the knowledge that E(Z|W )
is bounded between −1 and +1. The second method incorporates the bounds, but does so
at a cost in sample size by modeling E(Z|Z 6= 0,W ). The second method predicts a scaled
version of the parameter of interest, and so is still valid for making treatment decisions.
In the simulation and trial example presented here, the loss of sample size in the second
method greatly increased the variability of the final prediction. But both the simulation and
trial example had a high fraction of patients with Z = 0 (equivalently, Y = 0). The second
method may outperform the first method in settings where Pr(Y = 0) is very small. For the
examples presented here, no problems were observed with the first method not respecting
the bounds on E(Z|W ).
In the trial example, the super learner did perform better than the main terms linear
regression based on the estimate of the risk E(Ψn(W )−Z)2. Even though the super learner
has shown to have excellent performance across a range of simulations [2, 12] and in various
of our data analyses in breast cancer research, there is a risk that the super learner will
result in a slight over-fit. In the data analysis we observed that the super learner was ranked
third, but competitive with the top two candidate learners, LARS and MARS. We have also
proposed an extension to the super learner outlined here to adaptively select the number of
candidates [13] so that the weaker candidates are not selected, which we believe will protect
the super learner against possible over-fitting, but this was not implemented in the current
data analysis yet.
We observed that the difference in sample size between the two methods may make the
second method unusable in this example, but the two methods also differed in the treatment
of right censoring. The first method incorporated the doubly robust censoring unbiased
transformation while the second method used the inverse probability of censoring weights. If
the model for Q(W ) was correctly specified, but the model for the censoring mechanism was
not consistently estimating pi(W ), the doubly robust estimator would still be unbiased but
the inverse probability of censoring weighted method will be biased. Alternatively, if pi(W )
was correctly specified, but Q(W ) was inconsistent, then both methods will be unbiased.
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The doubly robust transformation gives the researcher two chances to correctly the nuisance
parameters, while the inverse weighting method relies solely on the model for pi(W ). When
there is uncertainty regarding the model for the censoring mechanism, the doubly robust
transformation is preferred.
The methods presented above are not limited to randomized clinical trials. Optimal
treatment prediction models could also be estimated from observational or registry data
sets. As long as the variables needed to estimate Pr(A = 1|W )) are collected in the study
the above methods easily extend to the non-randomized setting. Registry data sets are often
larger than randomized trials and therefore have more power to detect the interaction effects
necessary for predict optimal treatments.
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